Insiders ORIC Pharmaceuticals, Inc. Börse Stuttgart

Equities

Market Closed - Börse Stuttgart Other stock markets 15:14:10 28/06/2024 BST			5-day change	1st Jan Change
6.5 ^EUR	+3.17%		-4.41%	-20.25%

06-10	Transcript : ORIC Pharmaceuticals, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 10:40 AM
05-06	ORIC Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Oric Pharmaceuticals Insider Sold Shares Worth $648,380, According to a Recent SEC Filing	03-08	MT
Oric Pharmaceuticals Insider Sold Shares Worth $489,346, According to a Recent SEC Filing	02-09	MT
Investor Caution Ahead of GDP Data, Jobless Claims Subdues Exchange-Traded Funds, Equity Futures Premarket	22/12/22	MT
Insider Buy: Oric Pharmaceuticals	16/05/22	MT
Insider Buy: Oric Pharmaceuticals	28/03/22	MT
ORIC Pharmaceuticals, Inc. Announces Directorate Changes	10/11/21	CI
Insider Sell: Oric Pharmaceuticals	14/09/21	MT
Insider Sell: Oric Pharmaceuticals	09/09/21	MT
ORIC Pharmaceuticals, Inc. Announces Board Changes	16/08/21	CI
ORIC Pharmaceuticals Appoints Lori Kunkel to Its Board of Directors	09/06/20	CI
ORIC Pharmaceuticals, Inc. Appoints Christian V. Kuhlen as General Counsel	02/04/20	CI
ORIC Pharmaceuticals Appoints Mardi C. Dier to Its Board of Directors	02/03/20	CI
ORIC Pharmaceuticals Appoints Dominic Piscitelli as Chief Financial Officer	10/09/19	CI
ORIC Pharmaceuticals, Inc. Appoints Lori Friedman as Chief Scientific Officer	09/07/19	CI
ORIC Pharmaceuticals Names Edna Chow Maneval as Senior Vice President of Clinical Development	04/03/19	CI
ORIC Pharmaceuticals Appoints Matt Panuwat as Chief Business Officer	26/11/18	CI
ORIC Pharmaceuticals Appoints Pratik Multani as Chief Medical Officer	17/09/18	CI
ORIC Pharmaceuticals Announces Management Changes	07/05/18	CI
ORIC Pharmaceuticals, Inc. Announces Executive Changes	20/12/17	CI
ORIC Pharmaceuticals Announces Management Appointments	10/08/16	CI

No results for this search